Maryland Medical Cannabis Commission

The Commission received reports from the Executive Director regarding patient application processing, sales growth, and the implementation of mandatory telework for state agencies. The Policy Committee discussed proposed revisions to the laboratory technical authority and a new fine schedule, which was subsequently approved by the Commission. The Compliance Committee reported on several cases, including a consent order for a laboratory and a letter of surrender from a former grower agent. The Final Review Subcommittee presented recommendations resulting in the approval of an ancillary business registration for a security guard company and the issuance of a dispensary license for Green Life Wellness.

The commission meeting addressed several operational and regulatory updates. Topics included a staffing report detailing significant growth in personnel and medical cannabis program statistics for 2019. The executive director provided updates on the extension of dispensary operational dates, a ban on vitamin E acetate in medical cannabis vape products, and a new RFP for expanded laboratory testing. The board also approved regulatory changes regarding laboratory testing requirements for processed products, the adoption of a fine schedule to increase transparency and streamline administrative processes, and discussed the implementation of regulations for edible cannabis products, emphasizing safety, sanitation, and regulatory compliance.

The meeting included a report on registration statistics for medical cannabis patients and caregivers, an overview of the organization's staff growth, and the upcoming requirement for physical patient identification cards. The commission announced the opening of the application period for grower and processor licenses, noting the selection of Morgan State University to provide evaluator services. Additionally, the legislative director provided an update on pending bills, including those related to edibles, advertising, and license ownership limits. A regulatory update was provided regarding diversity regulations and the timeline for upcoming public comment periods. Finally, the commission discussed a bulletin regarding the rescission of dispensary licenses for businesses that are not licensed and operational by established deadlines.

The meeting focused on operational updates for the medical cannabis program, including application processing times, dispensary pre-approval stages, and ongoing public outreach efforts. Key discussions addressed technical issues with the Metrix system and the implementation of a new communication tool, Nixel, for broadcasting information. Representatives from law enforcement participated to discuss proposed regulatory amendments, specifically regarding the requirement for patients and caregivers to carry identification cards and keep medical cannabis in its original packaging to help distinguish between legitimate medical use and illegal activity.

The commission meeting focused on the discussion and approval of grant awards related to training and assisting small, minority, and women-owned businesses in the medical cannabis industry, as mandated by House Bill 2. The discussion covered the application evaluation process, the criteria used by subject matter experts, and the geographic diversity of the proposed services. Following questions regarding readiness and implementation timelines, the commission voted to approve the top five ranked applicants.